↓ Skip to main content

Vaccine Design

Overview of attention for book
Cover of 'Vaccine Design'

Table of Contents

  1. Book Overview
  2. Chapter 1 Challenges in Veterinary Vaccine Development and Immunization.
  3. Chapter 2 Development of Mycoplasma hyopneumoniae Recombinant Vaccines.
  4. Chapter 3 Computational Prediction of Immunodominant Epitopes on Outer Membrane Protein (Omp) H of Pasteurella multocida Toward Designing of a Peptide Vaccine.
  5. Chapter 4 DNA Vaccines Against Maedi-Visna Virus.
  6. Chapter 5 Detection of Avian Antigen-Specific T Cells Induced by Viral Vaccines.
  7. Chapter 6 Generation of Newcastle Disease Virus (NDV) Recombinants Expressing the Infectious Laryngotracheitis Virus (ILTV) Glycoprotein gB or gD as Dual Vaccines.
  8. Chapter 7 Vaccine Design
  9. Chapter 8 Development of Fasciola Vaccine in an Animal Model.
  10. Chapter 9 Development of Experimental Vaccines Against Liver Flukes.
  11. Chapter 10 Vaccine Design
  12. Chapter 11 DNA Vaccination in Chickens.
  13. Chapter 12 Selection of Vaccine Candidates for Fish Pasteurellosis Using Reverse Vaccinology and an In Vitro Screening Approach.
  14. Chapter 13 Development of Vaccines Against Nocardiosis in Fishes.
  15. Chapter 14 Design of an Immersion Vaccine Against Aeromonad Septicemia in Perch (Perca fluviatilis L.).
  16. Chapter 15 Prokaryotic Production of Virus-Like Particle Vaccine of Betanodavirus.
  17. Chapter 16 Design and Construction of Shrimp Antiviral DNA Vaccines Expressing Long and Short Hairpins for Protection by RNA Interference.
  18. Chapter 17 Developing Anti-tick Vaccines.
  19. Chapter 18 Host Immunization with Recombinant Proteins to Screen Antigens for Tick Control.
  20. Chapter 19 Vaccinomics Approach to Tick Vaccine Development.
  21. Chapter 20 Vaccine Design
  22. Chapter 21 Vaccine Design
  23. Chapter 22 Alphavirus-Based Vaccines.
  24. Chapter 23 Vaccine Design: Replication-Defective Adenovirus Vectors.
  25. Chapter 24 Generation of Lymphocytic Choriomeningitis Virus Based Vaccine Vectors.
  26. Chapter 25 Production of Japanese Encephalitis Virus-Like Particles Using Insect Cell Expression Systems.
  27. Chapter 26 Subunit Protein Vaccine Delivery System for Tuberculosis Based on Hepatitis B Virus Core VLP (HBc-VLP) Particles.
  28. Chapter 27 Formulation Studies During Preclinical Development of Influenza Hemagglutinin and Virus-Like Particle Vaccine Candidates.
  29. Chapter 28 Strategies for Vaccine Design Using Phage Display-Derived Peptides.
  30. Chapter 29 Production of Well-Characterized Virus-like Particles in an Escherichia coli-Based Expression Platform for Preclinical Vaccine Assessments.
  31. Chapter 30 Vaccine Design
  32. Chapter 31 Vaccine Design
  33. Chapter 32 Vaccine Design
  34. Chapter 33 Facile Method for the Production of Recombinant Cholera Toxin B Subunit in E. coli.
  35. Chapter 34 Immunoproteomic Approach for Screening Vaccine Candidates from Bacterial Outer Membrane Proteins.
  36. Chapter 35 Vaccine Design
  37. Chapter 36 Oral Rabies Vaccine Design for Expression in Plants.
  38. Chapter 37 Purification of Virus-Like Particles (VLPs) from Plants.
  39. Chapter 38 Transient Expression of Viral Proteins in Plants Using Agrobacterium tumefaciens.
  40. Chapter 39 Vaccine Design
  41. Chapter 40 Recombinant Botulinum Toxoids: A Practical Guide for Production.
  42. Chapter 41 Preparation of Multifunctional Liposomes as a Stable Vaccine Delivery-Adjuvant System by Procedure of Emulsification-Lyophilization.
  43. Chapter 42 Preparation of the Multifunctional Liposome-Containing Microneedle Arrays as an Oral Cavity Mucosal Vaccine Adjuvant-Delivery System.
  44. Chapter 43 Preparation and Characterization of PLGA Encapsulated Protective Antigen Domain 4 Nanoformulation.
  45. Chapter 44 Attenuated Salmonella sp. as a DNA Delivery System for Trypanosoma cruzi Antigens.
  46. Chapter 45 Poly-ε-caprolactone/Chitosan and Chitosan Particles: Two Recombinant Antigen Delivery Systems for Intranasal Vaccination.
  47. Chapter 46 Micro-fractional Epidermal Powder Delivery for Skin Vaccination.
  48. Chapter 47 Vaccine Design
  49. Chapter 48 The Web-Based DNA Vaccine Database DNAVaxDB and Its Usage for Rational DNA Vaccine Design.
  50. Chapter 49 MetaMHCpan, A Meta Approach for Pan-Specific MHC Peptide Binding Prediction.
  51. Chapter 50 A Cohesive and Integrated Platform for Immunogenicity Prediction.
  52. Chapter 51 The Regulatory Evaluation of Vaccines for Human Use.
  53. Chapter 52 Vaccines and IP Rights: A Multifaceted Relationship.
  54. Chapter 53 From the Bench to the Pharmacy: Protecting Innovation During Vaccine Development and Commercialization.
  55. Chapter 54 Intellectual Property in Vaccine Innovation: Impact of Recent Patent Developments.
Attention for Chapter 1: Challenges in Veterinary Vaccine Development and Immunization.

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#23 of 18,290)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
19 news outlets
policy
1 policy source
twitter
1 X user
bluesky
1 Bluesky user

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Chapter title
Challenges in Veterinary Vaccine Development and Immunization.
Chapter number 1
Book title
Vaccine Design
Published in
Methods in molecular biology, January 2016
DOI 10.1007/978-1-4939-3389-1_1
Pubmed ID
Book ISBNs
978-1-4939-3388-4, 978-1-4939-3389-1
Authors

Mark A. Chambers, Simon P. Graham, Roberto M. La Ragione, Chambers, Mark A., Graham, Simon P., La Ragione, Roberto M., Ragione, Roberto M.

Editors

Sunil Thomas

Abstract

In approaching the development of a veterinary vaccine, researchers must choose from a bewildering array of options that can be combined to enhance benefit. The choice and combination of options is not just driven by efficacy, but also consideration of the cost, practicality, and challenges faced in licensing the product. In this review we set out the different choices faced by veterinary vaccine developers, highlight some issues, and propose some pressing needs to be addressed.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Peru 1 1%
Unknown 87 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 11 13%
Student > Ph. D. Student 9 10%
Student > Master 9 10%
Researcher 7 8%
Other 4 5%
Other 17 19%
Unknown 31 35%
Readers by discipline
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 17 19%
Biochemistry, Genetics and Molecular Biology 12 14%
Agricultural and Biological Sciences 10 11%
Immunology and Microbiology 5 6%
Social Sciences 3 3%
Other 7 8%
Unknown 34 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 162. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2025.
All research outputs
#306,978
of 32,718,554 outputs
Outputs from Methods in molecular biology
#23
of 18,290 outputs
Outputs of similar age
#4,212
of 434,578 outputs
Outputs of similar age from Methods in molecular biology
#5
of 1,515 outputs
Altmetric has tracked 32,718,554 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,290 research outputs from this source. They receive a mean Attention Score of 4.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,578 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 1,515 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.